key: cord-0754382-4jvf8cc8 authors: Zachrison, Kori S.; Sharma, Richa; Wang, Yulun; Mehrotra, Ateev; Schwamm, Lee H. title: National Trends in Telestroke Utilization in a US Commercial Platform Prior to the COVID-19 Pandemic date: 2021-08-07 journal: J Stroke Cerebrovasc Dis DOI: 10.1016/j.jstrokecerebrovasdis.2021.106035 sha: 4b9256636a267bcc189828795e8208ed1863aa18 doc_id: 754382 cord_uid: 4jvf8cc8 OBJECTIVES: Most data on telestroke utilization come from single academic hub-and-spoke telestroke networks. Our objective was to describe characteristics of telestroke consultations among a national sample of telestroke sites on one of the most commonly used common vendor platforms, prior to the COVID-19 public health emergency. MATERIALS AND METHODS: A commercial telestroke vendor provided data on all telestroke consultations by two specialist provider groups from 2013-2019. Kendall's τ β nonparametric test was utilized to assess time trends. Generalized linear models were used to assess the association between hospital consult utilization and alteplase use adjusting for hospital characteristics. RESULTS: Among 67,736 telestroke consultations to 132 spoke sites over the study period, most occurred in the emergency department (90%) and for stroke indications (final clinical diagnoses: TIA 13%, ischemic stroke 39%, hemorrhagic stroke 2%, stroke mimics 46%). Stroke severity was low (median NIHSS 2, IQR 0–6). Alteplase was recommended for 23% of ischemic stroke patients. From 2013 to 2019, times from ED arrival to NIHSS, CT scan, imaging review, consult, and alteplase administration all decreased (p<0.05 for all), while times from consult start to alteplase recommendation and bolus increased (p<0.01 for both). Transfer was recommended for 8% of ischemic stroke patients. Number of patients treated with alteplase per hospital increased with increasing number of consults and hospital size and was also associated with US region in unadjusted and adjusted analyses. Longer duration of hospital participation in the network was associated with shorter hospital median door-to-needle time for alteplase delivery (39 min shorter per year, p=0.04). CONCLUSIONS: Among spoke sites using a commercial telestroke platform over a seven-year time horizon, times to consult start and alteplase bolus decreased over time. Similar to academic networks, duration of telestroke participation in this commercial network was associated with faster alteplase delivery, suggesting practice improves performance. Telemedicine can mitigate disparities in resource availability between emergency departments (EDs) in stroke care delivery, i.e., telestroke. 1À3 Availability of telestroke improves performance on stroke quality metrics, and in particular, to increase alteplase use. 4À10 Additionally, by providing 24/7 access to neurology consultation, telestroke has enabled many hospitals to meet stroke center certification requirements. There are various models for telestroke delivery, including the hub-and-spoke model in which consultations are provided by an academic hub and the hub-less model where consultations are provided via a for-profit telemedicine company-based model or private practice consultants. 11 Most research on telestroke has come from single academic hub-and-spoke telestroke networks and therefore only captures one set of experiences. To fill this gap in knowledge, we described trends in telestroke consultations from 2013 to 2019, among a national sample of 132 care locations using a commercial telestroke platform. We used data from a large, commercial, telehealth company that provides the software and the platform for telestroke delivery to physician service organizations. These organizations then use the telestroke infrastructure provided by the vendor to connect centralized stroke experts with patients at spoke sites receiving the telestroke services. The telehealth company also provides a stroke data collection tool that collects encounter-level data on telestroke consultations. Two sets of stroke experts are using the tool to provide care at 132 sites where the key data fields could be mapped to a common set of fields. One of these providers is a major physician services organization with a stroke team of about 15 specialists and serving many health systems at approximately 90 care locations (free-standing EDs and hospitals). The second provider is a major integrated delivery network in the western U.S. with a stroke team of about 30 specialists serving approximately 40 spokes (primarily hospitals, and 2 clinics). We included all telestroke encounters logged 2013-2019 by the two major providers. All data are fully de-identified and reported at the encounter level. The study was approved by the local Institutional Review Board. Requests to access the dataset from qualified researchers trained in human subject confidentiality protocols may be sent to the corresponding author. The telehealth company provided the data but did not influence our analytic plan or presentation of results. The dataset included characteristics of telestroke consultations, including location of consultation, time metrics for consultation, National Institutes of Health Stroke Scale (NIHSS), alteplase eligibility, alteplase recommendation, alteplase receipt, final clinical impression, and patient disposition. Table 2 We also characterized sites receiving telestroke consultation by the number of consults per year, hospital size (see Supplemental Table 1 for definitions), rurality based on Rural Urban Commuting Area (RUCA) code, 12 and US geographic region (Northeast, Midwest, South, West). Site-level outcomes of interest were at the site level and included the number of patients treated with alteplase per year and hospital-level performance on door-to-needle time for alteplase delivery. We use descriptive statistics to characterize consultations. Longitudinal changes in time-metrics were examined using generalized estimating equations. We examined the bivariate relationship between receiving hospital characteristics and performance on alteplase delivery as measured by door-to-needle time and number of patients treated with alteplase. We then used generalized estimating equations to examine the independent relationship between receiving hospital characteristics and alteplase performance. Characteristics of receiving sites included number of consults performed per year, hospital size, rurality, and region. All analyses were performed in SAS 9.4 (Cary, NC). The dataset included 67,736 telestroke encounters between 2013-2019 from 2 major specialist providers connected with 132 receiving sites ( Table 1 ). The vast majority of consultations (nearly 90%) took place in the ED. The telestroke consultant's diagnosis was stroke in 53.0% of cases (transient ischemic attack [TIA], 12.8%; ischemic stroke, 38.8%; hemorrhagic stroke 2.4%). Other common diagnoses included encephalopathy (7.1%), seizure (6.5%), and altered mental status (3.0%). NIHSS was recorded in 47,009 cases (69.4%); median NIHSS was 2 (IQR 0À6). Across all years (2013 to 2019), median time from ED arrival to consult request was 27 min (IQR 10.4À96.9), from consult request to call-back was 3.1 min (IQR 2.1À5.0), and from consult call-back to alteplase administration was 38 min (IQR 28À52 min). From 2013 to 2019, there were significant trends of decreasing times from the patient's arrival to: CT scan (median 15 min [IQR in 2013 to 4 min [3] [4] [5] [6] in 2019, p<0.001), teleconsultation (27 min There were 12,247 patients deemed eligible for endovascular intervention (30% of the 40,907 for whom the field was completed). Among thrombectomy-eligible patients, timeliness of imaging, consultation, and Among all patients with disposition recorded, the percentage of patients for whom transfer was recommended decreased over time from 8.5% in 2013 to 4.0% in 2018 (p<0.001). Site characteristics are presented in Table 2 . In bivariate analyses, larger hospitals, and those performing more consults per year had higher frequency of alteplase administration, while rural hospitals and those in the Northeast had lower frequency of alteplase administration. After accounting for other covariates, consult volume and hospital size remained significantly associated with alteplase administration frequency, and hospitals in the South were also more likely to have higher frequency of alteplase administration (Table 3) . Alteplase administration was administered to 1903 patients, and door-to-needle time was documented in 1152 (60.5%). Receiving hospital performance on door-toneedle time for alteplase delivery was not significantly associated with any spoke characteristics on bivariate or multivariable analysis (Table 4) . Likewise, door-to-imaging time and door-to-consult time and consult callback-toalteplase time were not significantly different by region, hospital size, rurality, or hospital consult volume, with the exception of longer times from arrival-to-consult request in the South. (354 min, p=0.03). Finally, we examined the relationship between duration of participation in the telestroke network and alteplase delivery metrics. There was no significant association between duration of participation and proportion of eligible patients treated with alteplase (increase of 0.03% additional patients per additional year, p=0.07). However, we did find that sites with longer duration of participation had shorter door-to-needle times for patients treated with alteplase. In adjusted analyses accounting for hospital size, rurality, and U.S. region, the door-to-needle time significantly decreased by 39 min for every year of affiliation with the network (p=0.04). We report data from 132 spokes using a commercial telestroke platform from 2013 to 2019. This included nearly 68,000 telestroke consultations (at least 3-fold more telestroke consultations than published cumulatively in the medical literature to date). Consultation time metrics significantly improved over the duration of the study period, including time to NIHSS assessment, CT scan, imaging However, we also found that time from call back to alteplase recommendation and administration significantly increased over time. We were surprised to find increasing times from consult call back to alteplase recommendation and administration. However, given that time from ED arrival to alteplase administration improved over time, one possibility for the increased time from callback to administration is that with more rapid time from arrival to consultation, the telestroke consultant was involved in the patient care at an earlier point in the ED course and prior to collection of all relevant data necessary for recommendation. This possibility is supported by our finding of a decrease in time from CT performance to consultation request over the study period. From 2013 to 2016, we found a declining trend in the number of consults conducted by each spoke per year, followed by an uptrend from 2016 to 2019. One possibility is that sites were responding to changes in clinical evidence. For example, the negative findings of the Interventional Management of Stroke (IMS) III trial in 2013 13 may have contributed to decreasing consultations related to patients potentially eligible for endovascular intervention until after 2015 when subsequent trials affirmed the benefit for eligible patients. 14À18 However any attempted explanation is purely speculative. Similarly, we were surprised to find a decrease in the percentage of patients with transfer recommended and decreasing percentages of patients treated with alteplase from 2013 to 2018. This stands in contrast to the literature describing increasing transfers and increasing rates of alteplase treatment over time among stroke patients. However, this sample represents a unique subset of sites caring for acute stroke patients and the sample includes patients with telestroke consultations called suspected stroke regardless of final diagnosis. Thus, the declining proportions of transfer recommendations and alteplase administration may be reflective of changes in the population of patients for whom telestroke consultations were called, or even changes in the sites and resources of the sites participating in the telestroke networks. We found that hospitals with higher frequency of consults also had more patients eligible for alteplase and a greater proportion of patients treated with alteplase. This may simply reflect a higher volume of eligible patients. However, when we limited to patients identified as eligible for alteplase, we also found that hospitals with increased consult frequency had higher rates of treatment among eligible patients. In addition, we found that sites with longer duration of participation had shorter door-toneedle times for patients treated with alteplase. These results are similar to previous work, finding that the intensity of a hospital's participation in a telestroke network is associated with improved performance on stroke care delivery. 10 These findings suggest that increased frequency of consultation has a direct benefit to performance on stroke care delivery. Potential mechanisms include improved performance through repeated practice and knowledge transmission during the telestroke interactions. These results add to the existing telestroke literature, as most previous reports have been based on academic huband-spoke model systems. 4, 6, 8, 10 We found a somewhat lower rate of alteplase delivery to stroke patients in our data relative to other academic hub-and-spoke networks. However only 54% of patients in our data had an ischemic stroke diagnosis at the conclusion of the telemedicine encounter. In contrast, other systems with reported rates of 15À20% have not included rate of stroke diagnosis or have explicitly focused on patients with acute ischemic (Table 5) . 4, 10 Well-designed stroke systems of care are paramount to ensure access to high-quality care delivery for all patients with stroke. 19, 20 Academic hub-and-spoke telestroke programs have an important role in the system of care, and an extensive body of literature affirms the value of the academic hub-and-spoke telestroke network. 1,5À7,9,10,21À23 Our findings suggest that commercial networks may also contribute to high-quality stroke care delivery, and fill gaps in access where academic hub-and-spoke programs have not emerged. Our results suggest that commercial platforms are able to provide a consistent benefit to patients with respect to alteplase delivery, and that receiving sites that are engaged in the process perform similarly to spoke hospitals in academic networks. It may be that the nature of the telestroke network is less important than the quality of the providers and of the connection. Our study does have limitations. While one of the first descriptions of stroke care delivery via telestroke on a national scale, the data are based on hospitals connected with only 2 major providers and may not be reflective of patterns in other networks or with other hub providers. Due to limitations of our data we are unable to characterize some important components of stroke presentation and course (e.g., hemorrhagic transformation, endovascular procedure metrics). We also are not able to characterize details of the consulting telestroke providers (e.g., fellowship training completion) or of spoke hospitals (e. g., stroke center status). Additionally, there were missing data for some fields (e.g., NIHSS, clinical impression) however data appear to be missing at random and should not have biased our results. Finally, we were unable to characterize how telestroke consultation contributed to some components of the stroke system of care (e.g., transfer times) because our data were limited to the initial telestroke consultation. Among 132 hospital sites receiving telestroke consultations via a commercial telestroke network, times to consult start and alteplase bolus decreased over time. However, performance varied by region and by telestroke consult volume. We found that duration of telestroke participation was associated with faster alteplase delivery, suggesting improved performance with increased practice opportunity. Overall, commercial telestroke networks appear to behave similarly to academic networks. KSZ, RS, AM have no disclosures to report. YW reports being employed by TelaDoc Health. LHS reports being a consultant on user interface design and usability to Life-Image. Funding: Agency for Healthcare Research and Quality (K08 HS024561, Zachrison); NIH/NINDS (R01 NS111952, Mehrotra) Supplementary material associated with this article can be found in the online version at doi:10.1016/j.jstrokecere brovasdis.2021.106035. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the american heart association/american stroke association Recommendations for the implementation of telemedicine within stroke systems of care Recommendations for the implementation of telehealth in cardiovascular and stroke care: a policy statement from the american heart association Safe and effective implementation of telestroke in a US community hospital setting Telemedicine for acute stroke: triumphs and pitfalls Using telemedicine to facilitate thrombolytic therapy for patients with acute stroke Virtual telestroke support for the emergency department evaluation of acute stroke Remote evaluation of acute ischemic stroke: reliability of national institutes of health stroke scale via telestroke Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study Frequent hub-spoke contact is associated with improved spoke hospital performance: results from the massachusetts general hospital telestroke network The status of telestroke in the united states USDA ERS -Rural-Urban Commuting Area Codes Endovascular therapy after intravenous t-PA versus t-PA alone for stroke Endovascular therapy for ischemic stroke A randomized trial of intraarterial treatment for acute ischemic stroke Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials Thrombectomy within 8 hours after symptom onset in ischemic stroke Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke Recommendations for the establishment of stroke systems of care: a 2019 update: a policy statement from the american stroke association A network approach to stroke systems of care Safe and effective implementation of telestroke in a US community hospital setting Remote evaluation of acute ischemic stroke Trends in telestroke care delivery: a 15-year experience of an academic hub and its network of spokes